Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTEDGinkgo Bioworks Holdings Inc Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2026 | 1 | -$1.32 | -$1.06 | -$1.21 |
| Q2 2026 | 1 | -$1.14 | -$0.91 | -$1.05 |
| Q3 2026 | 1 | -$1.32 | -$1.05 | -$1.21 |
| Q4 2026 | 1 | -$1.36 | -$1.09 | -$1.25 |
| Q1 2027 | 1 | -$1.54 | -$1.23 | -$1.41 |
| Q2 2027 | 1 | -$1.30 | -$1.04 | -$1.19 |
| Q3 2027 | 1 | -$1.19 | -$0.95 | -$1.09 |
| Q4 2027 | 1 | -$1.09 | -$0.87 | -$1.00 |
Ginkgo Bioworks Holdings Inc Earnings Date And Information
Ginkgo Bioworks Holdings Inc last posted its earnings results on Thursday, May 7th, 2026. The company reported $-1.39 earnings per share for the quarter, missing analysts' consensus estimates of $-1.21115 by $0.17885. The company had revenue of 19.47 M for the quarter and had revenue of 170.16 M for the year. Ginkgo Bioworks Holdings Inc has generated $-6 earnings per share over the last year ($-5.64 diluted earnings per share) and currently has a price-to-earnings ratio of -1.68. Ginkgo Bioworks Holdings Inc has not formally confirmed its next earnings publication date, but the company's estimated earnings date is N/A based on prior year's report dates.
Ginkgo Bioworks Holdings Inc Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 05/07/2026 | Q1 2026 | -$1.21 | -$1.39 | -0.18 | $42.93 M | $19.47 M |
| 02/26/2026 | Q4 2025 | -$1.80 | -$1.43 | 0.37 | $37.09 M | $33.40 M |
| 11/06/2025 | Q3 2025 | -$1.24 | -$1.45 | -0.21 | $38.95 M | $38.84 M |
| 08/07/2025 | Q2 2025 | -$1.44 | -$1.10 | 0.34 | $41.60 M | $49.60 M |
| 05/06/2025 | Q1 2025 | -$1.23 | -$1.68 | -0.45 | $38.80 M | $48.32 M |
| 02/25/2025 | Q4 2024 | -$1.45 | -$2.07 | -0.62 | $44.47 M | $43.85 M |
| 11/12/2024 | Q3 2024 | -$2.40 | -$1.08 | 1.32 | $44.99 M | $89.05 M |
| 08/08/2024 | Q2 2024 | -$3.20 | -$4.23 | -1.03 | $43.14 M | $56.21 M |
| 05/09/2024 | Q1 2024 | -$3.20 | -$3.32 | -0.12 | $45.97 M | $37.94 M |
| 02/29/2024 | Q4 2023 | -$3.60 | -$4.28 | -0.68 | N/A | $34.76 M |
| 11/08/2023 | Q3 2023 | -$3.60 | -$6.21 | -2.61 | N/A | $55.43 M |
| 08/09/2023 | Q2 2023 | -$3.60 | -$3.59 | 0.01 | N/A | $80.57 M |
| 05/10/2023 | Q1 2023 | -$3.60 | -$4.28 | -0.68 | N/A | $80.70 M |
| 03/13/2023 | Q4 2022 | N/A | -$3.78 | N/A | N/A | $98.29 M |
| 11/14/2022 | Q3 2022 | -$10.00 | -$16.44 | -6.44 | N/A | $66.40 M |
| 08/15/2022 | Q2 2022 | -$2.00 | -$16.51 | -14.51 | N/A | $144.62 M |
| 05/16/2022 | Q1 2022 | -$1.60 | -$14.69 | -13.09 | N/A | $168.41 M |
| 03/28/2022 | Q4 2021 | N/A | -$41.82 | N/A | N/A | $148.49 M |
| 11/15/2021 | Q3 2021 | -$1.60 | -$3.08 | -1.48 | N/A | $77.61 M |
| 08/16/2021 | Q2 2021 | N/A | -$1.67 | N/A | N/A | $43.64 M |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Ginkgo Bioworks Holdings Inc Earnings: FAQ's
The conference call for Ginkgo Bioworks Holdings Inc's latest earnings report can be listened to online.
The conference call transcript for Ginkgo Bioworks Holdings Inc's latest earnings report can be read online.
Ginkgo Bioworks Holdings Inc (:DNA) has a recorded annual revenue of $170.16 M.
Ginkgo Bioworks Holdings Inc (:DNA) has a recorded net income of $-312,763,000.Ginkgo Bioworks Holdings Inc has generated $-5.64 earnings per share over the last four quarters.
Ginkgo Bioworks Holdings Inc (:DNA) has a price-to-earnings ratio of -1.68 and price/earnings-to-growth ratio is -0.04.